about
Cell therapy to induce allograft tolerance: time to switch to plan B?Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational studyMature IgM-expressing plasma cells sense antigen and develop competence for cytokine production upon antigenic challengeImpact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network.Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsDetection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Recent advances in renal transplantation: antibody-mediated rejection takes center stageSoothing touch of CD31 protects endothelium during cellular immune responsesNon-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.Lymphoid neogenesis in chronic rejection: the murderer is in the house.Composite tissue allograft extends a helping hand to transplant immunologists.Is defective lymphatic drainage a trigger for lymphoid neogenesis?Topological determinants and consequences of adventitial responses to arterial wall injury.Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.L19. Lymphoid neogenesis in vascular chronic inflammation.Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.Mechanisms underlying human genetic diversity: consequence for anti-graft antibody responses.A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study.mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.An integrated view of immune monitoring in vascularized composite allotransplantation.Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs.B Cells Loaded with Synthetic Particulate Antigens: A Versatile Platform To Generate Antigen-Specific Helper T Cells for Cell Therapy.Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression.Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient.Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators.Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.Type III cryoglobulinemia complicated by renal cortical necrosis.Comment on "Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's synHypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study.Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking.Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection.
P50
Q27013040-65F9F840-6A9A-48D3-B2CC-2D843D1E9C4DQ28484885-F98F28E6-B517-46A8-8DA4-A025A4F9F742Q28817598-66C2E62C-BD5E-409B-B108-096B75374946Q30823219-C76755F2-5908-4123-9D02-D5A9B575FEEBQ33365038-CB30964B-811A-4F36-8317-8B13DCB71BE8Q34962680-4F068493-080F-43E6-BDC0-F9ED3D8B244AQ35027253-8EB85CA0-A178-485B-A59B-4CDF39A97AE2Q35659332-32F6C435-9BD5-4744-A88F-EA0E08BF5BD5Q36238316-ADE8444D-FF7F-48E4-AF16-CAA526BC1874Q36514864-637D5965-A76A-4374-81F2-5B0EC92A523DQ36552470-D8280BD0-91FC-44CB-9A8D-DFA6FC09241DQ36556748-30790E21-410D-4B28-A618-07C231060174Q36571605-E3282745-C735-4606-97AC-F20FBEB9B436Q36775078-1132D795-B6ED-40EB-A180-C4A6992B397EQ36905946-0E085312-5863-4944-98CF-852E73E98423Q37719213-2DAF63A1-99D8-48B5-A909-7F055B348BC7Q38088515-7E9C1565-1C29-49A6-B446-BBF4E4F5CD38Q38137320-06B3B721-260B-4061-9F58-622B4208280CQ38597010-4964BE3F-384A-40BB-8ECF-89CB9306C869Q38619244-A6A92DAF-3643-4092-A46F-0F964E690958Q38625160-F723D4ED-60DB-43D1-8F26-E00469C19C3AQ38731333-B6C22626-5DDE-4E3B-A79D-76688AFF034BQ38788242-42BD6E71-03A2-4426-AAAB-DD91F6B83D01Q38818479-2A838152-6134-4D4A-A3DA-81A3020F5F56Q38830846-F5DE7BC3-404A-4E92-A582-EA1A086C55B2Q38852846-B241AB3F-4254-40D8-8AF3-B21A4AD2A20DQ38925801-3AB8C6B8-DA26-4827-94D0-17E3B939BCDEQ39084586-AE08311B-D465-487D-828E-AC977A0B34F0Q40877684-516AD262-D481-434D-88D7-9737AB909B82Q40878039-863ABC73-1F9B-46B5-B992-BE970039E890Q41218003-410607E3-322F-4E84-A5E1-A8CC78B9FCF9Q42657479-D3705E4D-FC45-4B41-A6F0-975A0A5007C1Q43700035-EB66BB9F-3DBF-4C52-89D4-782FDBE601A2Q43737920-8D4B9024-F74E-4CC4-9C57-95BE603DABFCQ46373102-3CFC5826-0B76-44BF-8DD2-8A90996219C4Q46463504-4A8C31D4-ACA3-4CFC-AAFF-025A1C231033Q46771620-9285894F-9E4C-4B24-A727-8A5956909BFCQ48245968-298BF4E2-F882-4D32-A4D2-ED7020237B8DQ48972504-5E284CD1-656B-46B8-8EAF-8E2A4C79D853Q50088087-DA0D1317-66C7-495F-A4DD-2DFE56051817
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Olivier Thaunat
@ast
Olivier Thaunat
@en
Olivier Thaunat
@es
Olivier Thaunat
@nl
type
label
Olivier Thaunat
@ast
Olivier Thaunat
@en
Olivier Thaunat
@es
Olivier Thaunat
@nl
prefLabel
Olivier Thaunat
@ast
Olivier Thaunat
@en
Olivier Thaunat
@es
Olivier Thaunat
@nl
P31
P496
0000-0002-3648-8963